# FDA Inspection 1252042 - Janice Faulknor, M.D. - September 19, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/janice-faulknor-md/9b6cfbd8-2d56-4605-8337-7a14c317edcf
Source feed: FDA_Inspections

> FDA Inspection 1252042 for Janice Faulknor, M.D. on September 19, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252042
- Company Name: Janice Faulknor, M.D.
- Inspection Date: 2024-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252042 - 2024-09-19](https://www.globalkeysolutions.net/records/fda_inspections/janice-faulknor-md/fc0f74fd-c8b9-4932-a67f-34499078a318)
- [FDA Inspection 1198579 - 2022-12-08](https://www.globalkeysolutions.net/records/fda_inspections/janice-faulknor-md/9b60e0ce-c232-4d56-abe2-f35f7077baa6)

Company: https://www.globalkeysolutions.net/companies/janice-faulknor-md/bfe46dbd-6ca1-48dc-aa87-9ba9087b5e4a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c